Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea-Reference-Cited by-同舟云学术

Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea

Published:2021-11-15 Issue:6 Volume:15 Page:851-857
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Kim Hyun Jin¹^ORCID,Oh Seak Hee²^ORCID,Lee Sung Hee²^ORCID,Kim Yu-Bin²^ORCID,Kim Dae Yeon³^ORCID,Park Sang Hyoung⁴^ORCID,Ye Byong Duk⁴^ORCID,Yang Suk-Kyun⁴^ORCID,Kim Kyung Mo²^ORCID

Affiliation:

1. Department of Pediatrics, Chungnam National University Hospital, Daejeon, Korea

2. Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea

3. Department of Pediatric Surgery, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea

4. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2021/015/GNL015-06-851.pdf

Reference36 articles.

1. Crohn’s disease

2. Development of the Crohnʼs disease digestive damage score, the Lémann score

3. Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn’s Disease: A Single-Centre Experience

4. Long-term outcome of pediatric-onset Crohn’s disease: A population-based cohort study

5. Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn’s Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort Study;Journal of Crohn's and Colitis;2023-11-27

2. Features of Crohn's Disease Depending on the Age of Disease Onset;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-11-12

3. Current Role of Monoclonal Antibody Therapy in Pediatric IBD: A Special Focus on Therapeutic Drug Monitoring and Treat-to-Target Strategies;Children;2023-03-28

4. Adalimumab Therapy in Pediatric Crohn Disease: A 2-Year Follow-Up Comparing “Top-Down” and “Step-Up” Strategies;Journal of Pediatric Gastroenterology & Nutrition;2022-10-28

5. Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease – Data from the multicenter CEDATA-GPGE registry study;Frontiers in Pediatrics;2022-07-19